Immunovant (IMVT) Cash & Current Investments (2018 - 2026)
Immunovant's Cash & Current Investments came in at $797.8 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 33.2% from $598.91 million a year earlier but down 11.6% from the prior quarter.
Powered by 
Analysis
Immunovant (IMVT) Cash & Current Investments (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Immunovant's Cash & Current Investments was $902.11 million, up 26.4% from FY2025.
- Cash & Current Investments has increased in each of the last three fiscal years, with a five-year compound annual growth rate of 17.7% (FY2021 to FY2026).
- Going back by fiscal year, Cash & Current Investments was $713.97 million in FY2025 (+12.4%), $635.37 million in FY2024 (+68.7%), $376.53 million in FY2023 (-23.8%) and $493.82 million in FY2022 (+23.4%).
- The five-year range for quarterly Cash & Current Investments is $269.93 million (fiscal Q2 2024) to $994.53 million (fiscal Q3 2026).
- Year-over-year, Cash & Current Investments has increased for six consecutive quarters, with growth averaging 35.5% over the last eight quarters.
- The fastest year-over-year change in Cash & Current Investments over five years came in fiscal Q3 2026 (growth of 165.4%), and the weakest in fiscal Q3 2025 (a decline of 45.8%).
- Business Quant data shows IMVT's Cash & Current Investments at $902.11 million (Q4 2026), $994.53 million (Q3 2026) and $521.9 million (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Immunovant | 5.87 Bn | 2.65 Bn | - | 797.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 797.80 Mn |
| Mar 31, 2026 | 902.11 Mn |
| Dec 31, 2025 | 994.53 Mn |
| Sep 30, 2025 | 521.90 Mn |
| Jun 30, 2025 | 598.91 Mn |
| Mar 31, 2025 | 713.97 Mn |
| Dec 31, 2024 | 374.70 Mn |
| Sep 30, 2024 | 472.94 Mn |
| Jun 30, 2024 | 560.01 Mn |
| Mar 31, 2024 | 635.37 Mn |
| Dec 31, 2023 | 690.94 Mn |
| Sep 30, 2023 | 269.93 Mn |
| Jun 30, 2023 | 330.00 Mn |
| Mar 31, 2023 | 376.53 Mn |
| Dec 31, 2022 | 432.61 Mn |
| Sep 30, 2022 | 405.80 Mn |
| Jun 30, 2022 | 427.21 Mn |
| Mar 31, 2022 | 493.82 Mn |
| Dec 31, 2021 | 527.00 Mn |
| Sep 30, 2021 | 559.00 Mn |
API Access
Immunovant Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IMVT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "IMVT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IMVT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();